Zhou Xin, Li Yanwei, Yin Yongjun, Wang Yilan, Xie Wen, Ren Yulan
School of Acupuncture-Moxibustion and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
The Second Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
BMJ Open. 2024 Dec 23;14(12):e090964. doi: 10.1136/bmjopen-2024-090964.
Ischaemic heart disease (IHD) is a pathological process characterised by a blockage or non-obstructive accumulation of atherosclerotic plaques in the epicardial arteries. Percutaneous coronary intervention (PCI) is widely used in clinical practice to treat IHD. However, angina post PCI (APPCI) impairs quality of life and portends a worse prognosis. Hence, an effective and safe treatment option remains an urgent need for patients with APPCI. In recent years, there has been an increasing body of clinical trials regarding the use of acupuncture for the prevention and treatment of APPCI, and the results have indicated it might be a promising therapeutic intervention. However, to our knowledge, the potential benefits of acupuncture for the prevention and treatment of APPCI to justify either their recommendation or their clinical role have not been evaluated.
PubMed, Embase, Cochrane Library, Web of Science Core Collection, Chinese Biomedical Database, Chinese National Knowledge Infrastructure, Wanfang Database and VIP Database will be searched from inception to 8 June 2024 without language restrictions. Two investigators will independently screen studies, extract data, assess the risk of bias from randomised controlled trials (RCTs) and assess the risk of bias. The third reviewer will arbitrate any disagreements. Data synthesis and analysis will be conducted using the RevMan V.5.4 software. Subgroup analyses, sensitivity analysis, meta-regression and bias reporting assessments will be performed if necessary and appropriate. Finally, the quality of evidence from RCTs will be assessed using the Grading of Recommendations Assessment, Development, and Evaluation System tool.
Ethical approval is unnecessary since no private or confidential patient data will be included. The systematic review will be published in peer-reviewed journals.
CRD42024562116.
缺血性心脏病(IHD)是一种病理过程,其特征为心外膜动脉中动脉粥样硬化斑块的阻塞或非阻塞性积聚。经皮冠状动脉介入治疗(PCI)在临床实践中被广泛用于治疗IHD。然而,PCI术后心绞痛(APPCI)会损害生活质量并预示更差的预后。因此,对于APPCI患者而言,一种有效且安全的治疗选择仍然是迫切需求。近年来,关于使用针灸预防和治疗APPCI的临床试验越来越多,结果表明针灸可能是一种有前景的治疗干预措施。然而,据我们所知,针灸预防和治疗APPCI的潜在益处尚未得到评估,无法据此推荐或明确其临床作用。
将检索PubMed、Embase、Cochrane图书馆、Web of Science核心合集、中国生物医学数据库、中国知网、万方数据库和维普数据库,检索时间从建库至2024年6月8日,无语言限制。两名研究者将独立筛选研究、提取数据、评估随机对照试验(RCT)的偏倚风险并评估偏倚风险。第三位评审员将对任何分歧进行仲裁。将使用RevMan V.5.4软件进行数据合成与分析。如有必要且合适,将进行亚组分析、敏感性分析、meta回归和偏倚报告评估。最后,将使用推荐分级评估、制定和评价系统工具评估RCT的证据质量。
由于不纳入私人或保密的患者数据,无需伦理批准。系统评价将发表在同行评审期刊上。
PROSPERO注册号:CRD42024562116。